search
Genmab
Trends
- 1European shares gain as Genmab jumps and bond yields retreat▼European shares gain as Genmab jumps, bond yields retreat
European stock markets rose, with Danish biotech Genmab among the standout gainers after a sharp jump in its share price. The rally came as bond yields across the region retreated, easing pressure on equities. Investors welcomed the softer yields, which lifted overall sentiment on European exchanges.